The standard clinical technique for repairing peripheral nerve gaps is the use of autologous sensory nerve grafts. The present study tested whether a collagen tube filled with autologous platelet-rich fibrin could induce sensory and motor recovery across a 12-cm nerve gap repaired 3.25 years post trauma, and reduce or eliminate neuropathic pain. CLINICAL PRESENTATION: Two years postrepair, good ring and small finger motor function had developed that could generate 1 kg of force, and topographically correct 2-point discrimination and sensitivity to vibration in the small and ring finger and proximal but not distal wrist had developed. The patient's excruciating neuropathic pain was reduced to tolerable, and he avoided the indicated extremity amputation. The 12-cm-long nerve gap was bridged with a collagen tube filled with autologous plateletrich fibrin. CONCLUSION: We demonstrate that a conduit filled with platelet-rich fibrin can induce limited, but appropriate, sensory and motor recovery across a 12-cm nerve gap repaired 3.25 years post trauma, without sacrificing a sensory nerve, can reduce existing excruciating neuropathic pain to tolerable, and allow avoidance of an indicated upperextremity amputation. We believe the technique can be improved to induce more extensive and reliable neurological recovery.
A nnually, more than 50 000 peripheral nerve repair procedures are performed in the United States (National Center for Health Statistics, 1995) . Immediate neurorrhaphy of transected peripheral nerves leads to almost perfect neurological recovery, neurorrhaphy #14 days postlesion leads to good recovery in 49% of patients, and neurorrhaphy 14 days to 6 months leads to only reasonable recovery in 28% of patients. 1 One explanation for the reduced neurological recovery with nerve repairs performed at increasing time post trauma is that long-term axotomized neurons lose their ability to extend axons, 2 and that the denervated Schwann cells of the distal nerve stump lose their ability to synthesize and release neurotrophic factors required to induce axon regeneration. [3] [4] [5] [6] However, long-term transected axons can regenerate and reinnervate newly denervated muscles even after they have been transected for up to 22 years. 7 In addition, faster and more extensive generation of long-term axotomized axons can be induced if long-term axotomized neurons are electrically stimulated, or if neurotrophic factors are administered to induce the denervated distal nerve Schwann cells, causing them to release neurotrophic factors that promote regeneration of the axotomized neurons. 8 The lack of reinnervation of long-term denervated targets is generally attributed to their becoming irreversibly atrophied. [9] [10] [11] [12] However, this belief is not well founded. Although longterm denervated intrinsic muscles undergo irreversible atrophy, extrinsic muscle fibers do not and can be reinnervated. Therefore, following an ulnar nerve trauma, reinnervation must be established as soon as possible before the intrinsic muscle targets become irreversibly atrophied. This is most rapidly accomplished by performing median to ulnar nerve or tendon transfers rather than the slower nerve graft technique. 13 For extrinsic muscles, which do not become irreversibly atrophied, rapid reinnervation is not as critical. Additional evidence supports the survival of long-term denervated muscle fibers as follows: (1) denervated adult rat muscles survive and can be reinnervated more than 1 year postdenervation 14 ; (2) human muscle denervated up to 3 years contained atrophied, but intact muscle fibers among small immature myofibers. [15] [16] [17] Thus, clinical evidence shows that human muscle fibers do not irreversibly atrophy, which is probably applicable to sensory targets.
When severed nerve ends cannot be coupled because of the length of a nerve gap, the clinical standard for inducing neurological recovery across a nerve gap is to graft one or more lengths of autologous sensory nerve between the nerve ends. However, such grafts have limitations. One is that when sensory nerve grafts are used to bridge extremity peripheral nerve gaps, good neurological recovery is generally limited to gaps of 5 to 8 cm in length. However, it has recently been shown that 1 patient recovered neurological function when an 11-cm nerve gap was repaired by the use of a sural nerve graft. [18] [19] [20] [21] Another limitation of sensory nerve grafts is that they are considered beneficial generally when the nerve repair is performed ,9 months postlesion and in younger patients. [22] [23] [24] [25] [26] [27] Then, using sensory nerve grafts has the negative impact of creating a permanent sensory deficit. Therefore, it would be beneficial to have a nerve repair technique that was effective in inducing neurological recovery across long nerve gaps, for repairs performed at long times post trauma and that did not require creating a sensory deficit.
One explanation for sensory nerve grafts inducing limited axon regeneration and neurological recovery is that, although it is generally accepted that pure sensory peripheral nerve graft Schwann cells promote both sensory and motor axon regeneration, evidence shows that they are more effective in promoting sensory than motor axon regeneration. 28 Thus, the observed motor axon regeneration is due not as much to the sensory Schwann cells but to their laminin-rich extracellular matrix. 29 This is best explained by sensory nerve Schwann cells not releasing the appropriate combinations of factors required to promote motor axon regeneration. 29 Another explanation for limited axon regeneration is that the cells within sensory nerve grafts become ischemic, which creates a toxic environment that inhibits axon regeneration. [30] [31] [32] Alternative techniques have been tested for bridging nerve gaps to induce axon regeneration and neurological recovery. Among these are acellular nerve grafts, 33 empty collagen tubes, 34, 35 empty fibrin tube, 36 biocompatible noncollagen tubes, 37 collagen tubes filled with pure fibrin, 38 nerve grafts plus fibrin, 39 and arteries, veins, and muscle tubes. 40 These techniques are generally only as effective as autologous sensory nerve grafts and therefore are applied clinically. Despite their limitations, sensory nerve grafts remain the standard clinical technique for repairing nerve gaps.
METHODS

Patient Selection
A 48-year-old male patient presented at the University District Hospital 3.25 years following an ulnar nerve trauma at the elbow; he had no ulnar nerve function and was experiencing excruciating neuropathic pain. The patient had never undergone any previous nerve repair surgery and was seeking complete upper extremity amputation to reduce or eliminate his excruciating neuropathic pain, which was not being alleviated by morphine. The patient was offered the opportunity to participate in an institutional review board-approved nerve repair study with the guarantee of an extremity amputation if his pain was not reduced to what he considered a satisfactory level. The patient agreed to participate in the study.
Motor Recovery Analysis
Motor control was assessed by asking the patient to move, extend, and flex his fingers and hand, while muscle strength was determined with the use of a strain gauge. The extent of recovery of motor function of the operated hand was analyzed using the British Medical Research Council motor function scale, 25, 41 which involves a 6-point grading scale: grade 5, muscle contracts normally against full resistance; grade 4, muscle strength is reduced, but muscle contraction moves joint against resistance; grade 3, muscle strength is further reduced to where a joint can be moved only against gravity; grade 2, muscle can move only if the resistance of gravity is removed; grade 1, only a trace of movement is seen; grade 0, no movement is observed.
Sensory and Pain Analysis
The degree of the patient's pain was evaluated by asking the patient to classify his pain on a scale of 0 to 10, where 0 equaled no pain, and 10 equaled debilitating pain.
Sensitivity to touch was assessed by stroking the skin with a Q-tip, to cold temperature by wiping the skin with an alcohol swab, to pressure by pressing the skin with a fine stylus, to pain by pressing the skin with a pin, and to vibration by applying a tuning fork to the skin.
Following the initial assessment that the patient had no ulnar nerve motor or sensory function, exploratory surgery was performed to examine the site of the apparent nerve trauma. The ulnar nerve was found to be completely transected and to have a several centimeter gap, with many centimeters of macerated nerve. Based on these observations, it was decided that an electrophysiological assessment was not required. However, before the nerve repair, a second motor and sensory nerve function analysis was performed as described and no nerve motor or sensory function was found.
Preparation of Platelet-Rich Fibrin
After administering general anesthesia, but before any surgical interventions, 50 mL of whole blood were collected from a peripheral vein. The whole blood was put into an EBI Biomet Corp. (Warsaw, Indiana) disposable Gravitation Platelet Separation (GPS) centrifuge tube containing citrate-based anticoagulant, and the tube was placed in a GPS centrifuge where it was spun at 3200 rpm for 12 minutes leading to the separation of about 8 mL of highly concentrated unactivated platelet-rich fibrin.
Collagen Bridging Tube
Two 2 3 8 cm sheets of collagen (Veritas, Synovis Life Technologies, St. Paul, Minnesota), Food and Drug Administration-approved for soft tissue repair, were sewn end-to-end by using 3-0 polypropylene sutures and then into a tube with the use of polypropylene sutures, and the handle of a surgical tool with a diameter slightly larger than the nerve to be repaired was used as a template.
Surgery
Under full anesthesia, the ulnar nerve injury site was exposed at the elbow, showing nerve transection with massive maceration. The proximal nerve stump was refreshed to where, under visual inspection, it looked anatomically normal, and the distal nerve stump was refreshed to where no scarring was apparent under visual inspection. After the nerve stumps were refreshed, the nerve had a 12-cm long gap.
The 16-cm-long collagen tube was cut 8 mm longer than the nerve gap. This allowed both nerve ends to be secured 3 mm into the ends of the collagen tube with polypropylene sutures around the tube's entire circumference through the tube and the nerve epineurium (Figure, A) . The additional 2 mm of tube length were to avoid placing the repaired nerve under tension.
Autologous Platelet-Rich Fibrin
After securing the collagen tube in place, a fine cannula attached to a syringe filled with saline solution was inserted into the distal end of the tube, and the tube was flushed to wash out blood and any debris (Figure, B) .
A 10-mL syringe containing 8 mL of autologous platelet-rich fibrin and a 1-mL syringe containing thrombin plus calcium chloride were attached to 2 in-ports of a ratio mixer (Micromedics, Inc, St. Paul, Minnesota), and a fine flexible catheter was attached to the out-port. The catheter was inserted from the distal to the central end of the collagen tube, and was slowly withdrawn as the 2 syringe plungers were simultaneously pressed, causing the syringe contents to mix and be ejected, thus entirely filling the collagen tube (Figure, C) . The fibrin polymerized in about 20 seconds, and the incision was closed.
RESULTS
Pain Reduction
Slightly less than 3 months post surgery, but before any signs of neurological recovery, the patient's excruciating neuropathic pain began to decrease. By 1 year post surgery the patient's pain had decreased significantly and he had reduced his self-administered analgesic from morphine to a mild analgesic. By 1.5 years post surgery the patient stated that his neuropathic pain was so reduced that he no longer wanted an upper-extremity amputation. By 2 years post surgery the patient's neuropathic pain had decreased to a tolerable level, and he was no longer taking any analgesics.
Although by 2 years post surgery the patient still had some pain, it was no longer associated with the ulnar nerve injury site and had shifted from his hand to a specific region of the medial portion of his upper arm, where previously no pain had existed. He also had slight Tinel pain in the lower arm and hand, secondary to the nerve regeneration process. That pain continued to decrease, and the Tinel continued to extend further into the hand and fingers over the following 6 months.
Development of Sensitivity and Motor Function
By 3 months post surgery, the operated hand of the patient began to show signs of neurological recovery, starting with the development of topographic sensitivity in his hand appropriate for the ulnar nerve. By 1.5 years post surgery the patient had developed appropriate topographic 2-point discrimination of about 4 mm. Electromyelogram and evoked potential recordings indicated that the repaired nerve conduction velocity was still increasing. By 1.5 years after nerve repair, muscles associated with the repaired ulnar nerve began to twitch, indicating initiation of motor innervation. By 2 years post surgery, the patient had full flexion of superficial flexor muscles of his ring finger with motor force of grade 5 using the British Medical Research Council motor function scale. He also had extrinsic grade 4 motor function of his small and ring fingers, and the ability to move them and generate 1 kg of force. The intrinsic muscles had grade 0 function, with no movement observed. At that time, the patient was able to return to his original profession as a farmer, although doing lighter work than before the nerve trauma.
By 3 years after nerve repair, the patient had developed vibration sensitivity in his small and ring fingers, and in the proximal but not distal portion of his wrist.
DISCUSSION
Although autologous sensory nerve grafts are the standard clinical technique for repairing peripheral nerve gaps, they have FIGURE. Repair of a 12-cm ulnar nerve gap. A, 2 sheets of collagen sewn endto-end and then into a tube placed in the 12-cm-long nerve gap. B, the collagen tube being filled with platelet-rich fibrin. C, the collagen tube filled with autologous platelet-rich fibrin.
several limitations in inducing neurological recovery. Neurological recovery of extremity peripheral nerves (1) is generally good for nerve gaps 5 to 8 cm in length, but decreases with increasing gap length, and recovery has not been reported for gaps 12 cm or longer [42] [43] [44] [45] ; (2) decreases with increasing time between trauma and repair with no recovery for repairs performed .12 months after nerve trauma 2 ; (3) requires sacrificing a sensory nerve function; and (4) has no influence in reducing existing neuropathic pain. Although many alternative techniques have been tested, autologous sensory nerve grafts remain the standard for clinical peripheral nerve repair. 43, 46, 47 The present experiment was designed to determine whether neurological recovery could be induced across a 12-cm-long nerve gap bridged with a collagen tube filled with autologous plateletrich fibrin when the nerve repair was performed 3.25 years post trauma. It was also designed to determine whether of the technique influenced the degree of existing neuropathic pain.
Bridging the 12-cm nerve gap 3.25 years after an ulnar nerve trauma using only a collagen tube filled with autologous plateletrich fibrin led to recovery of both muscle and sensory function. The limited sensory and motor recovery might have resulted from applying the technique at the limits of its effectiveness, or that additional factors or techniques are simultaneously required to enhance the influence of the technique. However, even the recovery that was achieved was an enormous quality-of-life improvement for the patient, especially in reducing the excruciating neuropathic pain to tolerable, which allowed the patient to return to work and avoid an upper extremity amputation.
Extensive data from adult rat muscle denervation, atrophy, and reinnervation experiments show that rat muscles do not generally become reinnervated more than 9 months after denervation. 8 This is attributed to irreversible atrophy of the long-term denervated muscle fibers. [9] [10] [11] [12] 14 But even among animal models, denervation-triggered irreversible atrophy is not consistent. Oneyear denervated rat, but not rabbit tibialis anterior muscles show a 50 to 60% reduction in muscle mass and cross-sectional area, while rabbit, but not rat muscles can be reinnervated after 1 year of denervation. 48 The present study shows that adult human muscle fibers can be reinnervated 3.25 years after denervation. This result is consistent with data from a number of clinical studies showing that longterm denervated human muscles are resistant to atrophy, 49 human muscles retain the ability to be reinnervated through 2 years of denervation, 16 and that 3-year denervated human muscles retain large-diameter denervated muscle fibers, 17 and small immature myofibers are associated with the intact atrophied muscle fibers. 15 Therefore, not all long-term human muscle fibers atrophy irreversibly, and neurological function can be restored as shown in the present case. An important issue raised by these data is that caution is required when extrapolating from data from rat studies to other animal models or humans
The neurological recovery in the present study shows that long-term axotomized adult human sensory and motor neurons can extend axons. Because this is generally not observed when sensory nerve grafts are used, this suggests that platelet-released factors were responsible for inducing the axon regeneration. In addition, some of the platelet-released factors could also have interacted with denervated Schwann cells of the distal nerve to induce them to synthesize and release the factors that could contribute to promoting axon regeneration. 10 The successful neurological recovery in the present study was achieved with the use of the Biomet GPS Separation System. Without further similar studies using platelet-rich fibrin separated with the use of other techniques, we will not know whether the present success resulted specifically from using the Biomet BPS System or another aspect of the applied technique. Therefore, the reviewer raises the excellent point as to why multiple studies, all using platelet-rich fibrin, resulted in such different results, with our study on a 12-cm-long nerve gap showing neurological recovery, while other studies working with relatively short nerve gaps failed to find any neurological recovery. 50, 51 We hypothesize that the differences resulted from the use of different techniques to isolate the platelet-rich fibrin. To determine whether this is the case requires further experimental studies. Such studies would need to examine 3 parameters of the platelet-rich fibrin separation techniques. Under identical experimental conditions, it should be determined (1) what is the extent of axon regeneration and neurological recovery achieved when platelet-rich fibrin is separated from whole blood using different techniques; (2) what are the relative concentrations of separated platelets in the most successful techniques; (3) what are the relative yields of separated activated vs unactivated platelets in the successful techniques. A final important study would be to determine the minimum concentration of unactivated platelets required to induce sufficient axon regeneration to achieve neurological recovery and whether increasing the concentration of platelets increases the extent of axon regeneration and neurological recovery. Such studies would indicate which of the existing platelet separation techniques most reliably leads to sufficient axon regeneration and neurological recovery, and this information could lead to the development of a standardization of platelet separation techniques that are optimized for promoting axon regeneration and neurological recovery.
Neuropathic pain can be reduced, if only for short periods, by refreshing the central nerve stump or when transected axons reinnervate their targets. 52 Therefore, it is possible that the observed reduction in neuropathic pain resulted from refreshing the central nerve stump. However, the neuropathic pain began to be reduced before any neurological recovery started to develop and it was suppressed for more than 4 years. Both these observations suggest that the reduced pain resulted from the direct action of platelet-released factors on transected nociceptive axons.
CONCLUSION
The present data demonstrate that a human peripheral nerve gap up to 12 cm in length repaired up to 3.25 years after nerve trauma with a collagen tube filled with autologous platelet-rich fibrin can recover sensory and motor function. Simultaneously, this technique can reduce existing neuropathic pain from excruciating to tolerable, and it can avoid sacrificing a sensory nerve. Thus, this technique is more effective than the use of autologous sensory nerve grafts for this function. These results should encourage the application of this or similar techniques to induce enhanced axon regeneration and neurological recovery in patients with long nerve gaps and for any nerve gap repair that must be repaired at a long time post trauma. The significant reduction in neuropathic pain induced by the single application of platelet-rich fibrin to the refreshed central nerve stump suggests that this approach may also reduce chronic neuropathic pain in cases of painful peripheral neuropathies and for amputees experiencing severed nerve chronic pain.
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